Exact Mass: 627.2178626
Exact Mass Matches: 627.2178626
Found 82 metabolites which its exact mass value is equals to given mass value 627.2178626
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Chitin
C24H41N3O16 (627.2486706000001)
Chitin is one of the main components in the cell walls of fungi, the exoskeletons of insects and other arthropods (such as crustaceans) as well as fish and frogs. It is a polysaccharide that is constructed from units of acetylglucosamine (more completely, N-acetyl-D-glucose-2-amine). These are linked together in beta-1,4 fashion (in a similar manner to the glucose units which form cellulose). In effect, chitin may be described as cellulose with one hydroxyl group on each monomer replaced by an acetylamine group. This allows for increased hydrogen bonding between adjacent polymers, giving the polymer increased strength. Chitin is the second most abundant polysaccharide in the world (after cellulose). Chitinases break down chitin and are a part of the defence mechanism of mammals against chitin-containing parasites in lower life forms. Under certain circumstances, chitin can act as an allergen. Research using murine models has shown that chitin is a size-dependent microbial-associated molecular pattern (MAMP) that can induce an immunological response via pattern recognition receptors. Medium-sized chitin micro-particles (CMPs) have been shown to induce inflammation, while small-sized CMPs reduce inflammation. Additionally, mammalian chitinases may play a key role in mediating the T-helper 2 cell-driven inflammatory response that is commonly associated with asthma. The high prevalence of asthma among people working with chitinous substances, such as crabs and fungi, suggests that chitin might be an allergen playing a significant role in the development of asthma. Chitin is an unusual substance as it is a naturally occurring polymer. Its breakdown is conducted by bacteria which have receptors to simple sugars from the decomposition of chitin. If chitin is detected they then produce enzymes to digest the chitin by reducing it to simple sugars and ammonia.
Tri-N-acetylchitotriose
C24H41N3O16 (627.2486706000001)
Tri-N-acetylchitotriose is an oligosaccharide that may prevent the action of certain prolamins (antinutritional peptides) from some cereals (e. g. wheat, barley, and rye) that adversely affect in vivo the intestinal mucosa of coeliac patients. (PMID: 10399351) [HMDB] Tri-N-acetylchitotriose is an oligosaccharide that may prevent the action of certain prolamins (antinutritional peptides) from some cereals (e. g. wheat, barley, and rye) that adversely affect in vivo the intestinal mucosa of coeliac patients. (PMID: 10399351). N,N',N''-Triacetylchitotriose is a competitive inhibitor of lysozyme[1].
3'-Deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin
C32H37NO12 (627.2315642000001)
Lys-Cys-Thr-Cys-Cys-Ala
Pirarubicin
C32H37NO12 (627.2315642000001)
3-[2-Methoxy-4-[3-methoxy-4-(2-phenyl-1H-tetrazol-3-yl)phenyl]phenyl]-2-(4-nitrophenyl)-5-phenyl-1H-tetrazole
tetrahydropyranyl adriamycin
C32H37NO12 (627.2315642000001)
14-(4-acetoxy-3-methoxyphenyl)-3,11-diacetoxy-2,12-dimethoxy-8,9-dihydro-6H-chromeno[4,3:4,5]pyrrolo[2,1-a]isoquinolin-6-one|lamellarin chi triacetate|lamellarin-chi
1alpha,15-diacetoxy-9alpha-benzoyloxy-4beta,6beta,8beta-trihydroxy-2alpha-nicotinoyloxy-dihydro-beta-agarofuran
C32H37NO12 (627.2315642000001)
Glu Met Trp Tyr
Glu Met Tyr Trp
Glu Trp Met Tyr
Glu Trp Tyr Met
Glu Tyr Met Trp
Glu Tyr Trp Met
Met Glu Trp Tyr
Met Glu Tyr Trp
Met Trp Glu Tyr
Met Trp Tyr Glu
Met Tyr Glu Trp
Met Tyr Trp Glu
Trp Glu Met Tyr
Trp Glu Tyr Met
Trp Met Glu Tyr
Trp Met Tyr Glu
Trp Tyr Glu Met
Trp Tyr Met Glu
Tyr Glu Met Trp
Tyr Glu Trp Met
Tyr Met Glu Trp
Tyr Met Trp Glu
Tyr Trp Glu Met
Tyr Trp Met Glu
(g1CNAC)3
C24H41N3O16 (627.2486706000001)
N,N',N''-Triacetylchitotriose is a competitive inhibitor of lysozyme[1].
Pirarubicin
C32H37NO12 (627.2315642000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances D000970 - Antineoplastic Agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Zirconium, tris(3-aminophenolato-.kappa.O)2,2-bis(2-propenyloxy-.kappa.O)methyl-1-butanolato-.kappa.O-, (OC-6-22)-
Triacetylchitotriose
C24H41N3O16 (627.2486706000001)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
H-Lys-cys-thr-cys-cys-ala-OH trifluoroacetate salt
7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-3-(oxan-2-yl)-8,10-dihydro-7H-tetracene-5,12-dione
C32H37NO12 (627.2315642000001)
9,11-dihydroxy-9-(2-hydroxyacetyl)-7-[5-hydroxy-4-(2-methoxymorpholin-4-yl)-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C32H37NO12 (627.2315642000001)
beta-D-GlcpNAc-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc
C24H41N3O16 (627.2486706000001)
(S)-2-(4-(2-(2-Hydroxyethylthio)-acetamido)-benzyl)-1,4,7,10-tetraazacyclododecane-N,N,N,N-tetraacetate
C27H41N5O10S (627.2574006000001)
N-[(2S,3R)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C29H33N5O7S2 (627.1821308000001)
N-[(2R,3S)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C29H33N5O7S2 (627.1821308000001)
N-[(2R,3S)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C29H33N5O7S2 (627.1821308000001)
N-[(2S,3R)-2-[[(3,5-dimethyl-4-isoxazolyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-1,3-benzothiazole-2-carboxamide
C29H33N5O7S2 (627.1821308000001)
9-(Dimethylamino)-1-{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutyl}-2,2,4,11,11-pentamethyl-2,11-dihydronaphtho[2,3-g]quinolinium perchlorate
C32H38ClN3O8 (627.2347298000001)
beta-D-GlcpNAc-(1->4)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc
C24H41N3O16 (627.2486706000001)
2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->3)-[2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->6)]-2-acetamido-2-deoxy-D-galacto-hexopyranose
C24H41N3O16 (627.2486706000001)
GalNAcbeta1-4GalNAcbeta1-4GalNAcbeta
C24H41N3O16 (627.2486706000001)
GlcNAc(b1-3)[GlcNAc(b1-6)]b-GalNAc
C24H41N3O16 (627.2486706000001)
2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->3)-[2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->6)]-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
C24H41N3O16 (627.2486706000001)
GlcNAc(b1-4)[GlcNAc(b1-6)]b-GalNAc
C24H41N3O16 (627.2486706000001)
6-[2-[(1E,3E,5E,7Z)-7-(1-ethyl-5-sulfo-3H-indol-2-ylidene)hepta-1,3,5-trienyl]-5-sulfo-3H-indol-1-ium-1-yl]hexanoic acid
N,N,N-triacetylchitotriose
C24H41N3O16 (627.2486706000001)
N,N',N''-Triacetylchitotriose is a competitive inhibitor of lysozyme[1].
(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-6-methyl-5-[[(2R)-2-oxanyl]oxy]-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C32H37NO12 (627.2315642000001)
DAMGO (TFA)
DAMGO TFA is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR[1]. DAMGO TFA is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR[1].
4-(dimethylamino)-2,4-dimethyl-6-[(3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl)oxy]oxan-3-yl acetate
C32H37NO12 (627.2315642000001)
7-(acetyloxy)-12-[4-(acetyloxy)-3-methoxyphenyl]-8,16-dimethoxy-3-oxo-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14,16,18-octaen-17-yl acetate
(14z)-5,11-dihydroxy-6-[(4-hydroxy-3-iodophenyl)methyl]-3,7,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
(2s,3s,4s,6s)-4-(dimethylamino)-2,4-dimethyl-6-{[(1r,2r,3r)-3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl]oxy}oxan-3-yl acetate
C32H37NO12 (627.2315642000001)
(3s,6r,12s,14e,16r,18s)-5,11-dihydroxy-6-[(4-hydroxy-3-iodophenyl)methyl]-3,7,12,14,16,18-hexamethyl-1-oxa-4,7,10-triazacyclooctadeca-4,10,14-triene-2,8-dione
(2s,3r,4r,6r)-4-(dimethylamino)-2,4-dimethyl-6-{[(1r,2r,3r)-3,10,12-trihydroxy-2,7-dimethoxy-3-methyl-4,6,11-trioxo-1,2-dihydrotetracen-1-yl]oxy}oxan-3-yl acetate
C32H37NO12 (627.2315642000001)